Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Jun;227(6):821–831. doi: 10.1097/00000658-199806000-00005

Periampullary adenocarcinoma: analysis of 5-year survivors.

C J Yeo 1, T A Sohn 1, J L Cameron 1, R H Hruban 1, K D Lillemoe 1, H A Pitt 1
PMCID: PMC1191384  PMID: 9637545

Abstract

OBJECTIVE: This single-institution experience retrospectively reviews the outcomes in a group of patients treated 5 or more years ago by pancreaticoduodenectomy for periampullary adenocarcinoma. SUMMARY BACKGROUND DATA: Controversy exists regarding the benefit of resection for periampullary adenocarcinoma, particularly for pancreatic tumors. Many series report only Kaplan-Meier actuarial 5-year survival rates. There are believed to be discrepancies between the actuarial 5-year survival data and the actual 5-year survival rates. METHODS: From April 1970 through May 1992, 242 patients underwent pancreaticoduodenal resection for periampullary adenocarcinoma at The Johns Hopkins Hospital. Follow-up was complete through May 1997. All pathology specimens were reviewed and categorized. Actual 5-year survival rates were calculated. The demographic, intraoperative, pathologic, and postoperative features of patients surviving > or =5 years were compared with those of patients who survived <5 years. RESULTS: Of the 242 patients with resected periampullary adenocarcinoma, 149 (62%) were pancreatic primaries, 46 (19%) arose in the ampulla, 30 (12%) were distal bile duct cancers, and 17 (7%) were duodenal cancers. There was a 5.3% operative mortality rate during the 22 years of the review, with a 2% operative mortality rate in the last 100 patients. There were 58 5-year survivors, 28 7-year survivors, and 7 10-year survivors. The tumor-specific 5-year actual survival rates were pancreatic 15%, ampullary 39%, distal bile duct 27%, and duodenal 59%. When compared with patients who did not survive 5 years, the 5-year survivors had a significantly higher percentage of well-differentiated tumors (14% vs. 4%; p = 0.02) and higher incidences of negative resection margins (98% vs. 73%, p < 0.0001) and negative nodal status (62% vs. 31%, p < 0.0001). The tumor-specific 10-year actuarial survival rates were pancreatic 5%, ampullary 25%, distal bile duct 21%, and duodenal 59%. CONCLUSIONS: Among patients with periampullary adenocarcinoma treated by pancreaticoduodenectomy, those with duodenal adenocarcinoma are most likely to survive long term. Five-year survival is less likely for patients with ampullary, distal bile duct, and pancreatic primaries, in declining order. Resection margin status, resected lymph node status, and degree of tumor differentiation also significantly influence long-term outcome. Particularly for patients with pancreatic adenocarcinoma, 5-year survival is not equated with cure, because many patients die of recurrent disease >5 years after resection.

Full text

PDF
823

Images in this article

822Figure 1.
on p.822

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen H. B., Baden H., Brahe N. E., Burcharth F. Pancreaticoduodenectomy for periampullary adenocarcinoma. J Am Coll Surg. 1994 Nov;179(5):545–552. [PubMed] [Google Scholar]
  2. Barnes G., Jr, Romero L., Hess K. R., Curley S. A. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol. 1994 Jan;1(1):73–78. doi: 10.1007/BF02303544. [DOI] [PubMed] [Google Scholar]
  3. Brat D. J., Hahn S. A., Griffin C. A., Yeo C. J., Kern S. E., Hruban R. H. The structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma. Am J Pathol. 1997 Feb;150(2):383–391. [PMC free article] [PubMed] [Google Scholar]
  4. Cameron J. L., Pitt H. A., Yeo C. J., Lillemoe K. D., Kaufman H. S., Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993 May;217(5):430–438. doi: 10.1097/00000658-199305010-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chan C., Herrera M. F., de la Garza L., Quintanilla-Martinez L., Vargas-Vorackova F., Richaud-Patín Y., Llorente L., Uscanga L., Robles-Diaz G., Leon E. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg. 1995 Nov;222(5):632–637. doi: 10.1097/00000658-199511000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Conlon K. C., Klimstra D. S., Brennan M. F. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg. 1996 Mar;223(3):273–279. doi: 10.1097/00000658-199603000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Crile G., Jr The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet. 1970 Jun;130(6):1049–1053. [PubMed] [Google Scholar]
  8. Crist D. W., Sitzmann J. V., Cameron J. L. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg. 1987 Sep;206(3):358–365. doi: 10.1097/00000658-198709000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Delcore R., Jr, Connor C. S., Thomas J. H., Friesen S. R., Hermreck A. S. Significance of tumor spread in adenocarcinoma of the ampulla of Vater. Am J Surg. 1989 Dec;158(6):593–597. doi: 10.1016/0002-9610(89)90201-8. [DOI] [PubMed] [Google Scholar]
  10. Fernández-del Castillo C., Rattner D. W., Warshaw A. L. Standards for pancreatic resection in the 1990s. Arch Surg. 1995 Mar;130(3):295–300. doi: 10.1001/archsurg.1995.01430030065013. [DOI] [PubMed] [Google Scholar]
  11. Fortner J. G., Klimstra D. S., Senie R. T., Maclean B. J. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg. 1996 Feb;223(2):147–153. doi: 10.1097/00000658-199602000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Geer R. J., Brennan M. F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993 Jan;165(1):68–73. doi: 10.1016/s0002-9610(05)80406-4. [DOI] [PubMed] [Google Scholar]
  13. Gordon T. A., Cameron J. L. Management of patients with carcinoma of the pancreas. J Am Coll Surg. 1995 Dec;181(6):558–560. [PubMed] [Google Scholar]
  14. Gudjonsson B. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg. 1995 Dec;181(6):483–503. [PubMed] [Google Scholar]
  15. Gudjonsson B. Management of patients with carcinoma of the pancreas. J Am Coll Surg. 1996 Sep;183(3):290–291. [PubMed] [Google Scholar]
  16. Kayahara M., Nagakawa T., Ohta T., Kitagawa H., Miyazaki I. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery. 1997 Jun;121(6):611–617. doi: 10.1016/s0039-6060(97)90048-9. [DOI] [PubMed] [Google Scholar]
  17. Kurosaki I., Tsukada K., Hatakeyama K., Muto T. The mode of lymphatic spread in carcinoma of the bile duct. Am J Surg. 1996 Sep;172(3):239–243. doi: 10.1016/S0002-9610(96)00156-0. [DOI] [PubMed] [Google Scholar]
  18. Lillemoe K. D., Cameron J. L., Yeo C. J., Sohn T. A., Nakeeb A., Sauter P. K., Hruban R. H., Abrams R. A., Pitt H. A. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996 Jun;223(6):718–728. doi: 10.1097/00000658-199606000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lygidakis N. J., van der Heyde M. N., Allema J. H., Tytgat G. N., Houthoff H. J., van Leeuwen D. Subtotal duodenopancreatectomy for pancreatic duct, distal bile duct and periampullary carcinoma: short- and long-term results. Am J Gastroenterol. 1989 Aug;84(8):917–920. [PubMed] [Google Scholar]
  20. Martin F. M., Rossi R. L., Dorrucci V., Silverman M. L., Braasch J. W. Clinical and pathologic correlations in patients with periampullary tumors. Arch Surg. 1990 Jun;125(6):723–726. doi: 10.1001/archsurg.1990.01410180041008. [DOI] [PubMed] [Google Scholar]
  21. Matory Y. L., Gaynor J., Brennan M. Carcinoma of the ampulla of Vater. Surg Gynecol Obstet. 1993 Oct;177(4):366–370. [PubMed] [Google Scholar]
  22. Michelassi F., Erroi F., Dawson P. J., Pietrabissa A., Noda S., Handcock M., Block G. E. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg. 1989 Oct;210(4):544–556. doi: 10.1097/00000658-198910000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Monson J. R., Donohue J. H., McEntee G. P., McIlrath D. C., van Heerden J. A., Shorter R. G., Nagorney D. M., Ilstrup D. M. Radical resection for carcinoma of the ampulla of Vater. Arch Surg. 1991 Mar;126(3):353–357. doi: 10.1001/archsurg.1991.01410270099016. [DOI] [PubMed] [Google Scholar]
  24. Moossa A. R., Gamagami R. A. Diagnosis and staging of pancreatic neoplasms. Surg Clin North Am. 1995 Oct;75(5):871–890. doi: 10.1016/s0039-6109(16)46733-2. [DOI] [PubMed] [Google Scholar]
  25. Nagorney D. M., Donohue J. H., Farnell M. B., Schleck C. D., Ilstrup D. M. Outcomes after curative resections of cholangiocarcinoma. Arch Surg. 1993 Aug;128(8):871–879. doi: 10.1001/archsurg.1993.01420200045008. [DOI] [PubMed] [Google Scholar]
  26. Nakeeb A., Pitt H. A., Sohn T. A., Coleman J., Abrams R. A., Piantadosi S., Hruban R. H., Lillemoe K. D., Yeo C. J., Cameron J. L. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996 Oct;224(4):463–475. doi: 10.1097/00000658-199610000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pickleman J., Koelsch M., Chejfec G. Node-positive duodenal carcinoma is curable. Arch Surg. 1997 Mar;132(3):241–244. doi: 10.1001/archsurg.1997.01430270027004. [DOI] [PubMed] [Google Scholar]
  28. Pitt H. A., Dooley W. C., Yeo C. J., Cameron J. L. Malignancies of the biliary tree. Curr Probl Surg. 1995 Jan;32(1):1–90. doi: 10.1016/s0011-3840(05)80011-5. [DOI] [PubMed] [Google Scholar]
  29. Rozenblum E., Schutte M., Goggins M., Hahn S. A., Panzer S., Zahurak M., Goodman S. N., Sohn T. A., Hruban R. H., Yeo C. J. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 1997 May 1;57(9):1731–1734. [PubMed] [Google Scholar]
  30. Shapiro T. M. Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs Whipple resection in good risk patients. Ann Surg. 1975 Dec;182(6):715–721. doi: 10.1097/00000658-197512000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sohn T. A., Lillemoe K. D., Cameron J. L., Pitt H. A., Kaufman H. S., Hruban R. H., Yeo C. J. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg. 1998 Jan-Feb;2(1):79–87. doi: 10.1016/s1091-255x(98)80107-8. [DOI] [PubMed] [Google Scholar]
  32. Spitz F. R., Abbruzzese J. L., Lee J. E., Pisters P. W., Lowy A. M., Fenoglio C. J., Cleary K. R., Janjan N. A., Goswitz M. S., Rich T. A. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997 Mar;15(3):928–937. doi: 10.1200/JCO.1997.15.3.928. [DOI] [PubMed] [Google Scholar]
  33. Talamini M. A., Moesinger R. C., Pitt H. A., Sohn T. A., Hruban R. H., Lillemoe K. D., Yeo C. J., Cameron J. L. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg. 1997 May;225(5):590–600. doi: 10.1097/00000658-199705000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tarazi R. Y., Hermann R. E., Vogt D. P., Hoerr S. O., Esselstyn C. B., Jr, Cooperman A. M., Steiger E., Grundfest S. Results of surgical treatment of periampullary tumors: a thirty-five-year experience. Surgery. 1986 Oct;100(4):716–723. [PubMed] [Google Scholar]
  35. Trede M., Schwall G., Saeger H. D. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg. 1990 Apr;211(4):447–458. doi: 10.1097/00000658-199004000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tsao J. I., Rossi R. L., Lowell J. A. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation. Arch Surg. 1994 Apr;129(4):405–412. doi: 10.1001/archsurg.1994.01420280081010. [DOI] [PubMed] [Google Scholar]
  37. Wade T. P., Coplin M. A., Virgo K. S., Johnson F. E. Periampullary cancer treatment in U.S. Department of Veterans Affairs hospitals: 1987-1991. Surgery. 1994 Oct;116(4):819–826. [PubMed] [Google Scholar]
  38. Wade T. P., Halaby I. A., Stapleton D. R., Virgo K. S., Johnson F. E. Population-based analysis of treatment of pancreatic cancer and Whipple resection: Department of Defense hospitals, 1989-1994. Surgery. 1996 Oct;120(4):680–687. doi: 10.1016/s0039-6060(96)80017-1. [DOI] [PubMed] [Google Scholar]
  39. Wade T. P., el-Ghazzawy A. G., Virgo K. S., Johnson F. E. The Whipple resection for cancer in U.S. Department of Veterans Affairs Hospitals. Ann Surg. 1995 Mar;221(3):241–248. doi: 10.1097/00000658-199503000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Washburn W. K., Lewis W. D., Jenkins R. L. Aggressive surgical resection for cholangiocarcinoma. Arch Surg. 1995 Mar;130(3):270–276. doi: 10.1001/archsurg.1995.01430030040006. [DOI] [PubMed] [Google Scholar]
  41. Whipple A. O., Parsons W. B., Mullins C. R. TREATMENT OF CARCINOMA OF THE AMPULLA OF VATER. Ann Surg. 1935 Oct;102(4):763–779. doi: 10.1097/00000658-193510000-00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Willett C. G., Warshaw A. L., Convery K., Compton C. C. Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma. Surg Gynecol Obstet. 1993 Jan;176(1):33–38. [PubMed] [Google Scholar]
  43. Yeo C. J., Abrams R. A., Grochow L. B., Sohn T. A., Ord S. E., Hruban R. H., Zahurak M. L., Dooley W. C., Coleman J., Sauter P. K. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg. 1997 May;225(5):621–636. doi: 10.1097/00000658-199705000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yeo C. J., Cameron J. L. Alternative techniques for performing the Whipple operation. Adv Surg. 1996;30:293–310. [PubMed] [Google Scholar]
  45. Yeo C. J., Cameron J. L., Lillemoe K. D., Sitzmann J. V., Hruban R. H., Goodman S. N., Dooley W. C., Coleman J., Pitt H. A. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995 Jun;221(6):721–733. doi: 10.1097/00000658-199506000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yeo C. J., Cameron J. L., Sohn T. A., Lillemoe K. D., Pitt H. A., Talamini M. A., Hruban R. H., Ord S. E., Sauter P. K., Coleman J. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997 Sep;226(3):248–260. doi: 10.1097/00000658-199709000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES